Successful use of dupilumab to treat eczema in a child with X-linked agammaglobulinemia

We described here a child with X-linked agammaglobulinemia (XLA) who developed severe generalized eczema that was unresponsive to mid-potency topical corticosteroid but eventually responded to dupilumab. The patient is an 11 year-old male who initially presented to our clinic at 11 months of age after he was discharged from an outside pediatric intensive care unit due to respiratory distress needing intubation and assisted ventilation. He was treated with intravenous antibiotics and eventually recovered.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Source Type: research